Lengthening adalimumab dosing interval in quiescent Crohn’s disease patients: protocol for the pragmatic randomised non-inferiority LADI study

por Smits, L J T, Pauwels, R W M, Kievit, W, de Jong, D J, de Vries, A C, Hoentjen, F, van der Woude, C J
Publicado 2020